Inspire Medical Systems
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Inspire Medical Systems sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Inspire Medical Systems: 8 sponsored US clinical trials, 4 recruiting.
Inspire Medical Systems sponsors 8 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obstructive Sleep Apnea, with 3 trials.
Upper-quartile sponsor footprint
Inspire Medical Systems sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
NCT07113288
Pediatric Down Syndrome Post-Approval Study
NCT06851338
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
NCT05428839
Pediatric Post-Approval Registry
NCT04457154
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
NCT04801771
Inspire® Post-Approval Study / Protocol Number 2014-001
NCT02413970
Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing)
NCT04416542
Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)
NCT01161420
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Therapeutic Areas
Where Inspire Medical Systems enrollment is open (later-stage tilt)
4 recruiting of 8 indexed (50% open); 2 completed (25%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Obstructive Sleep Apnea (3 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Inspire Medical Systems: open-pipeline peers nationwide
Peers matched on 8 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Inspire Medical Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Inspire Medical Systems page
8 registered trials is a research-attention snapshot, not an endorsement of Inspire Medical Systems or any single study.
- 4 of Inspire Medical Systems's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obstructive Sleep Apnea is the condition Inspire Medical Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obstructive Sleep Apnea trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Inspire Medical Systems pipeline card: 8 registered trials from official public datasets.Report a data error.